Ionis Pharmaceuticals | IONS - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Agios Pharmaceuticals USD 19.43M 1.34M 2026-03
Alnylam Pharmaceuticals USD 825M 4.3M 2026-03
Arrowhead Research USD 264.03M 7.56M 2025-12
Astellas Pharma JPY 444.26B 12.55B 2026-03
BioCryst Pharmaceuticals USD 153.05M 4.16M 2025-12
BioMarin Pharmaceutical USD 571.21M 141.8M 2026-03
Celltrion KRW 46.98B 579.12B 2025-12
Cspc Pharmaceutical CNY 4.01B 329.18M 2025-12
Deva Holding AS TRY 1.32B 235.77M 2023-09
Divis Laboratories Ltd INR 16.59B 2.05B 2025-12
Esperion Therapeutics USD 140.59M 94.57M 2025-12
Exelixis USD 590.86M 18.68M 2026-03
Halozyme Therapeutics USD 297.47M 75.53M 2026-03
Ionis Pharmaceuticals USD 243M 48M 2026-03
Kangmei Pharma CNY 238.34M 31.95M 2026-03
Knight Therapeutics CAD 64.72M 8.91M 2025-12
Laboratorios Farma EUR 105.28M 177.08M 2025-06
Medical Developments International AUD 7.35M 7.37M 2025-06
Moderna USD -566M 792M 2026-03
Nektar Therapeutics USD 21.81M 8.06M 2025-12
Neuren Pharmaceuticals AUD 6.69M 6.37M 2025-06
Neurocrine Biosciences USD 800.7M 12.8M 2026-03
Novartis USD 10.07B 184M 2026-03
Omeros USD -33.16M 18.52M 2024-06
OPKO Health USD 45M 1.89M 2025-12
Organigram Holdings CAD 23.32M 8.52M 2025-12
Pfizer USD 11.04B 1.24B 2026-03
Pharma Mar EUR 39.24M 47.46M 2026-03
PTC Therapeutics USD 232.94M 84.56M 2026-03
Qiagen NV USD 325.27M 19.53M 2025-12
Regeneron Pharmaceuticals USD 2.94B 363.7M 2026-03
Roche Holding CHF 22.09B 10.04B 2025-12
Sarepta Therapeutics USD 621.34M 577.79M 2026-03
Sartorius EUR 414.5M 18.3M 2026-03
Sino Biopharmaceutical CNY 10.5B 2.53B 2024-12
Tilray USD 57.47M 10.16M 2025-06
Ultragenyx Pharmaceutical USD 106M 72M 2026-03
Vertex Pharmaceuticals USD 2.6B 121.7M 2026-03
Zealand Pharma A/S 68.91M 19.35M 2025-12
Zz Pientze Pharmaceu CNY 1.16B 860.2M 2026-03